Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.
J M BaeHan Hee LeeBo In LeeK-M LeeS H EunM-L ChoJ S KimJ M ParkY-S ChoI S LeeS W KimH ChoiMyung-Gyu ChoiPublished in: Alimentary pharmacology & therapeutics (2018)
The risks of psoriasiform diseases are increased by anti-TNF agents in patients with IBD. Among psoriasiform diseases, the risk of palmoplantar pustulosis shows the biggest increase particularly in male and younger patients.